Recovery Kinetics Following a Soccer Training in Middle-aged Males

February 19, 2024 updated by: Ioannis G. Fatouros, University of Thessaly
This study aims at investigating the recovery kinetics of skeletal muscle damage, neuromuscular fatigue and performance following a single soccer trainning session in middle aged males. The participants will perform a soccer training session [A single training session including 60 minutes of warm up, soccer technical exercises and small-sided game] and a cotrol trial (No intervention included, only daily measurements) in randomized, repeated measures, crossover design. Assesesments related to skeletal muscle damage, performance and neuromuscular fatigue will be executed before the training session and daily for four consecutive days after training.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

Eleven male middle-aged participants will be included in this study. Participants will be initially informed about the main goals of study as well as the associated risks and benefits and then will provide their signed consent form. At baseline, they will undergo assessment of their anthropometrics (body mass, height, BMI, WHR), body compotition (using DXA), physical contition level (peak oxygen consumption, VO2peak), haemodynamic profile (diastolic and diastolic blood pressure) and daily dietary intake.Thereafter, they will participate in two experimental trials (Control trial and Soccer trial) in a randomized, crossover, repeated measure design: 1) ST (Soccer Trial): Participants in this trial will perform a soccer training session (60 min) consisted of warm-up, technical exercises and small-sided game, CT (Control Trial): Participants in this trial will only execute the evaluations daily in the dependent variables (they will not receive any intervention). Before each trial, the participants will provide a resting blood sample (for the determination of white blood cells, granulocyte cells, monocyte cells, lymphocyte cells, Hemeatocrit, Hemoglobin, red blood cells and platelets, total antioxidant capacity, glutathione and creatine kinase activity) and undergo assessments of their delay onset muscle soreness (DOMS), maximal voluntary isometric contraction (MVIC) of knee extensors and flexors (by isokinetic dynamometer), height and power of countermovement jump (CMJ-using force platform), 10m and 30m sprint time (will be evaluated using light cells). A 7-day wash-out period will apllied between ST and CT. The blood sample will be collected before and 24, 48 and 72 hours post-taining. Also, the evaluation of DOMS, MVIC, sprinting performance, power and jump height (by CMJ) will be evaluated before and 24, 48, 72 and 96 hours post training.

Study Type

Interventional

Enrollment (Estimated)

11

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Athanasios Z Jamurtas, Prof
  • Phone Number: +30 24310 47054
  • Email: ajamurt@pe.uth.gr

Study Locations

      • Tríkala, Greece, 42100
        • Recruiting
        • University o Thessaly, School of Physical Education and Sports Science
        • Principal Investigator:
          • Athanasios S Poulios, PhD
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Free of musculoskeletal injuries
  • No use of ergogenic supplements or medication
  • Free of chronic diseases
  • age of 40-60 years

Exclusion Criteria:

  • Musculoskeletal injury
  • Use of alcohol, caffeine and any type of ergogenic supplements or medication during the course of the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Participants in this arm will receive no intervention
Experimental: ST
Participants in this arm will participate in a soccer training (ST) session for 60 minutes. During the training the participans will execute the warm-up process, the part of soccer technical exercises and they will play a small-side-game.
Participants will perform a soccer training (ST) session for 60 minutes. The training will include the warm-up, soccer technical exercises and a small-side game

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in White blood cell count
Time Frame: At baseline, at 24, 48 and 72 hours after soccer training
White blood cell count will be measured using an automatic blood analyzer
At baseline, at 24, 48 and 72 hours after soccer training
Change in Granulocyte cell count
Time Frame: At baseline, at 24, 48 and 72 hours after soccer training
Change in White blood cell count will be measured using an automatic blood analyzer
At baseline, at 24, 48 and 72 hours after soccer training
Change in Platelets cell count
Time Frame: At baseline, at 24, 48 and 72 hours after soccer training
Platelets cell count will be measured using an automatic blood analyzer
At baseline, at 24, 48 and 72 hours after soccer training
Change in Monocyte cell count
Time Frame: At baseline, at 24, 48 and 72 hours after soccer training
Monocytes cell count will be measured using an automatic blood analyzer
At baseline, at 24, 48 and 72 hours after soccer training
Change in Lymphocyte cell count
Time Frame: At baseline, at 24, 48 and 72 hours after soccer training
Lymphocyte cell count will be measured using an automatic blood analyzer
At baseline, at 24, 48 and 72 hours after soccer training
Change in percentage of Hematocrit level
Time Frame: At baseline, at 24, 48 and 72 hours after soccer training
The percentage of Hematocrit level will be measured using an automatic blood analyzer
At baseline, at 24, 48 and 72 hours after soccer training
Change Red blood cells count
Time Frame: At baseline, at 24, 48 and 72 hours after soccer training
Red blood cells count will be measured using an automatic blood analyzer
At baseline, at 24, 48 and 72 hours after soccer training
Change in Hemoglobin level
Time Frame: At baseline, at 24, 48 and 72 hours after soccer training
Hemoglobin level will be measured using an automatic blood analyzer
At baseline, at 24, 48 and 72 hours after soccer training
Change in Creatine kinase activity
Time Frame: At baseline, at 24, 48 and 72 hours after soccer training
Creatine kinase activity will be measured in plasma
At baseline, at 24, 48 and 72 hours after soccer training
Change in Total antioxidant capacity
Time Frame: At baseline, at 24, 48 and 72 hours after soccer training
Total antioxidant capacity will be measured in plasma
At baseline, at 24, 48 and 72 hours after soccer training
Change in Glutathione concentration in blood
Time Frame: At baseline, at 24, 48 and 72 hours after soccer training
Glutathione concentration will be measured in red blood cells
At baseline, at 24, 48 and 72 hours after soccer training
Change in countermovement jump height
Time Frame: At baseline, at 24, 48, 72 and 96 hours after soccer training
countermovement jump height will be measured using a force platform
At baseline, at 24, 48, 72 and 96 hours after soccer training
Change in Peak power during coutermovement jump test
Time Frame: At baseline, at 24, 48, 72 and 96 hours after soccer training
The peak power will be measured using a force platform
At baseline, at 24, 48, 72 and 96 hours after soccer training
Change in isometric peak torque of knee extensors and flexors
Time Frame: At baseline, at 24, 48, 72 and 96 hours after soccer training
Isometric peak torque will be assessed on an isokinetic dynamometer
At baseline, at 24, 48, 72 and 96 hours after soccer training
Change in sprint time of 10 m
Time Frame: At baseline, at 24, 48, 72 and 96 hours after soccer training
10m sprint time will be assessed using light cells
At baseline, at 24, 48, 72 and 96 hours after soccer training
Change in sprint time of 30 m
Time Frame: At baseline, at 24, 48, 72 and 96 hours after soccer training
30m sprint time will be assessed using light cells
At baseline, at 24, 48, 72 and 96 hours after soccer training
Change in delayed onset of muscle soreness
Time Frame: At baseline, at 24, 48, 72 and 96 hours after soccer training
Muscle soreness will be assessed by palpation of muscle belly and the distal region
At baseline, at 24, 48, 72 and 96 hours after soccer training

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lean body mass
Time Frame: At baseline
Lean body mass will be measured by using Dual-emission X-ray absorptiometry
At baseline
Dietary intake
Time Frame: At baseline
Dietary intake will be assesed over a 7-day period using diet recalls
At baseline
Peak Maximal oxygen consumption (Peak VO2)
Time Frame: At baseline
Peak VO2 will be estimated by open circuit spirometry via breath by breath method
At baseline
Body Mass
Time Frame: At baseline
Body Mass will be measured on a beam balance with stadiometer
At baseline
Body Height
Time Frame: At baseline
Body Height will be measured on a beam balance with stadiometer
At baseline
Body Fat
Time Frame: At baseline
Body Fat will be measured by using Dual-emission X-ray absorptiometry
At baseline
Bone mass density
Time Frame: At baseline
Bone mass density will be measured by using Dual-emission X-ray absorptiometry
At baseline
Bone mass content
Time Frame: At baseline
Bone mass content will be measured by using Dual-emission X-ray absorptiometry
At baseline
Field activity during the soccer training
Time Frame: During the 60 minutes soccer training (ST) session (72 hours after baseline measurements)
The field activity will be continuously monitored during the soccer training using global positioning system (GPS)
During the 60 minutes soccer training (ST) session (72 hours after baseline measurements)
Heart rate during the soccer training
Time Frame: During the 60 minutes soccer training (ST) session (72 hours after baseline measurements)
Heart rate will be continuously monitored during the soccer training using heart rate monitors
During the 60 minutes soccer training (ST) session (72 hours after baseline measurements)
Systolic Blood Pressure
Time Frame: At baseline
Systolic Blood Pressure will be examined using sphygmomanometer
At baseline
Dystolic Blood Pressure
Time Frame: At baseline
Dystolic Blood Pressure will be examined using sphygmomanometer
At baseline
Rest Heart Rate
Time Frame: At baseline
The rest heart rate will be estimated using a heart rate monitor
At baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Ioannis G Fatouros, Prof, University of Thessaly

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 5, 2024

Primary Completion (Estimated)

February 26, 2024

Study Completion (Estimated)

March 9, 2024

Study Registration Dates

First Submitted

January 29, 2024

First Submitted That Met QC Criteria

February 6, 2024

First Posted (Actual)

February 15, 2024

Study Record Updates

Last Update Posted (Estimated)

February 21, 2024

Last Update Submitted That Met QC Criteria

February 19, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • FFH

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Skeletal Muscle Damage

Clinical Trials on ST

3
Subscribe